Search Results

PQ 401 100mg 100mg  | Purity Not Available

Adooq Bioscience

PQ 401 is a cell-permeable phenylquinolinyl-urea compound that inhibits IGF-1R autophosphorylation.

More Information Supplier Page

PQ 401 10mg 10mg  | Purity Not Available

Adooq Bioscience

PQ 401 is a cell-permeable phenylquinolinyl-urea compound that inhibits IGF-1R autophosphorylation.

More Information Supplier Page

Zotarolimus 5mg 5mg  | Purity Not Available

Adooq Bioscience

Zotarolimus is an immunosuppressant. It is a semi-synthetic derivative of rapamycin. It was designed for use in stents with phosphorylcholine as a carrier.

More Information Supplier Page

Zotarolimus 25mg 25mg  | Purity Not Available

Adooq Bioscience

Zotarolimus is an immunosuppressant. It is a semi-synthetic derivative of rapamycin. It was designed for use in stents with phosphorylcholine as a carrier.

More Information Supplier Page

Zotarolimus 2mg 2mg  | Purity Not Available

Adooq Bioscience

Zotarolimus is an immunosuppressant. It is a semi-synthetic derivative of rapamycin. It was designed for use in stents with phosphorylcholine as a carrier.

More Information Supplier Page

P505-15 10mM * 1mL in DMSO 10mM * 1mL in DMSO  | Purity Not Available

Adooq Bioscience

P505-15 (also known as PRT062607) is a novel, highly selective, and orally bioavailable small molecule SYK inhibitor (SYK IC(50) = 1 nM) with anti-SYK activity that is at least 80-fold greater than its affinity for other kinases.

More Information Supplier Page

P505-15 25mg 25mg  | Purity Not Available

Adooq Bioscience

P505-15 (also known as PRT062607) is a novel, highly selective, and orally bioavailable small molecule SYK inhibitor (SYK IC(50) = 1 nM) with anti-SYK activity that is at least 80-fold greater than its affinity for other kinases.

More Information Supplier Page